文献速递前列腺癌

罕见ATM胚系变异增加前列腺癌易感性:PRACTICAL联盟研究

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
PubMed 文献 · Eur Urol Oncol · 2021-01-09

该研究基于PRACTICAL联盟13个研究组共5560例欧洲裔前列腺癌病例和3353例对照,分析下一代测序数据中罕见ATM变异与前列腺癌风险的关联。结果显示,携带1级(可能致病)ATM胚系变异者前列腺癌风险升高,总体OR为4.4(95%CI 2.0-9.5);2级(可能有害)变异亦与风险相关,OR为1.4(95%CI 1.1-1.7)。

要点

  • 携带可能致病ATM胚系变异者前列腺癌风险约升高4倍。
  • ATM致病变异携带者可能更早发生前列腺癌(<65岁)。
  • 结果可用于对男性及其家属进行遗传咨询。

核心结论

  • 携带致病性ATM变异者前列腺癌风险升高,且早发性疾病风险增加。

研究设计与样本

  • PRACTICAL联盟13个研究组的下一代测序数据分析,纳入5560例病例和3353例欧洲裔对照。

主要发现

  • 1级(可能致病)ATM胚系变异携带者前列腺癌风险总体OR为4.4(95%CI 2.0-9.5)。
  • 诊断年龄<65岁的前列腺癌病例中1级变异频率升高(pdifference=0.04)。
  • 2级(可能有害)变异与前列腺癌风险相关,OR为1.4(95%CI 1.1-1.7)。

临床怎么用

  • 可将ATM胚系致病变异信息用于男性及其家属的风险咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Germline ATM mutations are suggested to contribute to predisposition to prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant effect sizes. OBJECTIVE: To precisely estimate the contribution of germline ATM mutations to PrCa risk. DESIGN, SETTING, AND PARTICIPANTS: We analysed next-generation sequencing data from 13 PRACTICAL study groups comprising 5560 cases and 3353 controls of European ancestry. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Variant Call Format files were harmonised, annotated for rare ATM variants, and classified as tier 1 (likely pathogenic) or tier 2 (potentially deleterious). Associations with overall PrCa risk and clinical subtypes were estimated. RESULTS AND LIMITATIONS: PrCa risk was higher in carriers of a tier 1 germline ATM variant, with an overall odds ratio (OR) of 4.4 (95% confidence interval [CI]: 2.0-9.5). There was also evidence that PrCa cases with younger age at diagnosis (<65 yr) had elevated tier 1 variant frequencies (pdifference = 0.04). Tier 2 variants were also associated with PrCa risk, with an OR of 1.4 (95% CI: 1.1-1.7). CONCLUSIONS: Carriers of pathogenic ATM variants have an elevated risk of developing PrCa and are at an increased risk for earlier-onset disease presentation. These results provide information for counselling of men and their families. PATIENT SUMMARY: In this study, we estimated that men who inherit a likely pathogenic mutation in the ATM gene had an approximately a fourfold risk of developing prostate cancer. In addition, they are likely to develop the disease earlier.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Karlsson Q, Brook MN, Dadaev T, et al. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study. Eur Urol Oncol. 2021. PMID: 33436325. doi:10.1016/j.euo.2020.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。